Zobrazeno 1 - 2
of 2
pro vyhledávání: '"de Siqueira, Paula Sue Facundo"'
Autor:
de Paula, Ellen Alves, Silva, Rafael Augusto Mantovani, de Siqueira, Paula Sue Facundo, de Melo, Daniela Oliveira
Publikováno v:
Cadernos Ibero-Americanos de Direito Sanitário; v. 8 n. 4 (2019): (OUT./DEZ. 2019); 145-155
Iberoamerican Journal of Health Law; Vol. 8 No. 4 (2019): (OUT./DEZ. 2019); 145-155
Cuadernos Iberoamericanos de Derecho Sanitario; Vol. 8 Núm. 4 (2019): (OUT./DEZ. 2019); 145-155
Cadernos Ibero-Americanos de Direito Sanitário
Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
Iberoamerican Journal of Health Law; Vol. 8 No. 4 (2019): (OUT./DEZ. 2019); 145-155
Cuadernos Iberoamericanos de Derecho Sanitario; Vol. 8 Núm. 4 (2019): (OUT./DEZ. 2019); 145-155
Cadernos Ibero-Americanos de Direito Sanitário
Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
Objective: to describe the regulatory aspects of larotrectinib, the first approved drug with indication for tumor-agnosis in Brazil, and its likely impacts on judicialization in the country. Methods: this is a descriptive exploratory study. Results a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3056::5ea5eb58d56898ea36c8e9a5297e9428
https://www.cadernos.prodisa.fiocruz.br/index.php/cadernos/article/view/572
https://www.cadernos.prodisa.fiocruz.br/index.php/cadernos/article/view/572
Autor:
de Oliveira, Daniel Buffone, Silva, Rafael Augusto Mantovani, de Paula, Ellen Alves, Cassamassimo, Raphael Pereira, de Siqueira, Paula Sue Facundo, de Melo, Daniela Oliveira
Publikováno v:
Cadernos Ibero-Americanos de Direito Sanitário; v. 8 n. 3 (2019): (JUL./SET. 2019); 27-47
Iberoamerican Journal of Health Law; Vol. 8 No. 3 (2019): (JUL./SET. 2019); 27-47
Cuadernos Iberoamericanos de Derecho Sanitario; Vol. 8 Núm. 3 (2019): (JUL./SET. 2019); 27-47
Cadernos Ibero-Americanos de Direito Sanitário
Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
Iberoamerican Journal of Health Law; Vol. 8 No. 3 (2019): (JUL./SET. 2019); 27-47
Cuadernos Iberoamericanos de Derecho Sanitario; Vol. 8 Núm. 3 (2019): (JUL./SET. 2019); 27-47
Cadernos Ibero-Americanos de Direito Sanitário
Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
Objectives: The drug approval minimally guarantees the safety in the label directions. With the judgment of Extraordinary Appeal No. 67718, this issue is not pacified. The aim of this study is to compare the indications approved by the American (FDA)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3056::e8a22bad9546bf4c87f8c988b73788b8
https://www.cadernos.prodisa.fiocruz.br/index.php/cadernos/article/view/571
https://www.cadernos.prodisa.fiocruz.br/index.php/cadernos/article/view/571